Since G6P functions as a metabolic pre-cursor that can feed into both glycolysis and glycogenesis pathways [35], we next examined if knockdown of Drp1 promotes the conversion of glucose and G6P into glycogen via glycogenesis in colon cancer cells. Here, DNM1L is linked to malignant colon neoplasm.